These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28860486)

  • 1. A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancer.
    Gasa L; Sanchez-Botet A; Quandt E; Hernández-Ortega S; Jiménez J; Carrasco-García MA; Simonetti S; Kron SJ; Ribeiro MP; Nadal E; Villanueva A; Clotet J
    Sci Rep; 2017 Aug; 7(1):10228. PubMed ID: 28860486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atypical cyclin CNTD2 promotes colon cancer cell proliferation and migration.
    Sánchez-Botet A; Gasa L; Quandt E; Hernández-Ortega S; Jiménez J; Mezquita P; Carrasco-García MÀ; Kron SJ; Vidal A; Villanueva A; Ribeiro MPC; Clotet J
    Sci Rep; 2018 Aug; 8(1):11797. PubMed ID: 30087414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
    Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
    J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
    Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R
    Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Expression of
    Gong M; Song E; Huang G; Ni W; Dong W; Yuan R
    Front Genet; 2021; 12():579900. PubMed ID: 33613629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.
    Bircan HA; Gurbuz N; Pataer A; Caner A; Kahraman N; Bayraktar E; Bayraktar R; Erdogan MA; Kabil N; Ozpolat B
    Lung Cancer; 2018 Oct; 124():31-39. PubMed ID: 30268477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
    Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X
    Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.
    Wang G; Guo C; Zhao H; Pan Z; Zhu F; Zhang L; Wang Q
    BMC Cancer; 2018 Mar; 18(1):260. PubMed ID: 29510688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
    Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
    J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
    Jiang GY; Zhang XP; Wang L; Lin XY; Yu JH; Wang EH; Zhang Y
    Tumour Biol; 2016 Oct; 37(10):14311-14319. PubMed ID: 27596142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A positive feedback loop of IL-17B-IL-17RB activates ERK/β-catenin to promote lung cancer metastasis.
    Yang YF; Lee YC; Lo S; Chung YN; Hsieh YC; Chiu WC; Yuan SF
    Cancer Lett; 2018 May; 422():44-55. PubMed ID: 29496538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
    Ge Q; Cong P; Ji Y
    IUBMB Life; 2019 Nov; 71(11):1806-1814. PubMed ID: 31419016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 5 promotes the proliferation and invasion of lung cancer cells.
    Zhong L; Sun S; Yao S; Han X; Gu M; Shi J
    Oncol Rep; 2018 Oct; 40(4):2224-2232. PubMed ID: 30066893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
    Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
    Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis.
    Caputi M; De Luca L; Papaccio G; D'Aponte A; Cavallotti I; Scala P; Scarano F; Manna M; Gualdiero L; De Luca B
    Eur J Histochem; 1997; 41(2):133-8. PubMed ID: 9271706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of translationally controlled tumor protein inhibits growth, migration and invasion of lung cancer cells.
    Wang L; Tang Y; Zhao M; Mao S; Wu L; Liu S; Liu D; Zhao G; Wang X
    Life Sci; 2018 Jan; 193():292-299. PubMed ID: 28970113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
    Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
    Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.